Table 1 The synergistic effects of BE with carbendazim.
Treatment BE : carbendazim | Toxicity regression equation | EC50 (mg L−1) | Relative coefficient | CTC | 95% Confidence intervals (mg L−1) |
---|---|---|---|---|---|
5:1 | y = 1.6555x + 4.3786 | 2.37 × 10–2 | 0.9893 | 70.88 | 2.08 × 10–2–2.74 × 10–2 |
7:1 | y = 2.0388x + 4.1671 | 2.56 × 10–2 | 0.9928 | 87.50 | 2.29 × 10–2–2.85 × 10–2 |
9:1 | y = 1.1738x + 4.3865 | 2.25 × 10–2 | 0.9846 | 124.44 | 1.89 × 10–2–2.66 × 10–2 |
15:1 | y = 1.2661x + 4.3554 | 3.20 × 10–2 | 0.9948 | 139.95 | 2.88 × 10–2–3.56 × 10–2 |
49:1 | y = 2.2446x + 1.1381 | 23.20 × 10–2 | 0.9894 | 26.64 | 47.79 × 10–2–57.85 × 10–2 |
99:1 | y = 1.3652x + 1.8851 | 191.30 × 10–2 | 0.9865 | 14.63 | 166.6 × 10–2–223.20 × 10–2 |